[Research progress of super enhancer in cancer]
- PMID: 30686784
- DOI: 10.16288/j.yczz.18-152
[Research progress of super enhancer in cancer]
Abstract
Super enhancers (SEs) are composed of clusters of enhancers in close genomic proximity. They constitute a large family of regulatory elements that specify gene expression patterns and cell identity. SE regions consist of unusually strong enrichment of binding sites for transcriptional factors, cofactors, and enhancers associated with epigenetic modifications. SEs play important roles in regulating the aberrant gene expression in tumor cells. Via SEs, cancer cells activate the expression of various oncogenes, and promote cell proliferation, invasion and migration properties. Hence suppression of SEs activities could inhibit the growth and survival of cancer cells. In this review, we summarize the fundamental principles, functions and regulation of super enhancers and therapeutic potential in targeting SEs in cancer cells, thereby introducing and providing new conceptions for development of antineoplastic drugs.
Similar articles
-
The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.Int J Biol Sci. 2023 Jan 22;19(4):1036-1048. doi: 10.7150/ijbs.78535. eCollection 2023. Int J Biol Sci. 2023. PMID: 36923930 Free PMC article. Review.
-
Super enhancer lncRNAs: a novel hallmark in cancer.Cell Commun Signal. 2024 Apr 2;22(1):207. doi: 10.1186/s12964-024-01599-6. Cell Commun Signal. 2024. PMID: 38566153 Free PMC article. Review.
-
Super-enhancers complexes zoom in transcription in cancer.J Exp Clin Cancer Res. 2023 Jul 28;42(1):183. doi: 10.1186/s13046-023-02763-5. J Exp Clin Cancer Res. 2023. PMID: 37501079 Free PMC article. Review.
-
Super-enhancers in cancer.Pharmacol Ther. 2019 Jul;199:129-138. doi: 10.1016/j.pharmthera.2019.02.014. Epub 2019 Mar 16. Pharmacol Ther. 2019. PMID: 30885876 Review.
-
The molecular understanding of super-enhancer dysregulation in cancer.Nagoya J Med Sci. 2022 May;84(2):216-229. doi: 10.18999/nagjms.84.2.216. Nagoya J Med Sci. 2022. PMID: 35967935 Free PMC article. Review.